Belite Bio BLTE
NASDAQ BLTE
$150.27 -2.91 (-1.90%)
At close: Oct 22, 2026 · 4:00 PM EDT

Belite Bio (BLTE) Depreciation & Amortization (CF) (2024 - 2025)

Updated

Belite Bio's Depreciation & Amortization (CF) came in at $45,000 for Q4 2025, up 4.7% from $43,000 a year earlier.

Analysis

Belite Bio (BLTE) Depreciation & Amortization (CF) (2024 - 2025) Analysis & Trends

For FY2025, Belite Bio's Depreciation & Amortization (CF) was $464,000, up 3.3% from FY2024.

  • Depreciation & Amortization (CF) has increased in each of the last five years, with a five-year compound annual growth rate of 93.7% (FY2020 to FY2025).
  • Going back by year, Depreciation & Amortization (CF) was $449,000 in FY2024 (+12.5%), $399,000 in FY2023 (+101.5%), $198,000 in FY2022 (+560.0%) and $30,000 in FY2021 (+76.5%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 534.00 Mn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 2.12 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 194.00 Mn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn -
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 1.93 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 1.11 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 98.00 Mn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 1.62 Bn
10 Belite Bio 5.04 Bn 5.04 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 45,000.00
Dec 31, 2024 43,000.00
API Access

Belite Bio Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=BLTE&period=max&api_key=YOUR_API_KEY